Haemoglobin-S Testing Managed Service Contract
- NHS Wales Shared Services Partnership
- Wales
- Open procedure
- 1 April 2026 to 31 March 2031
Provision of a managed service for Haemoglobin-S testing to identify sickle cell trait in blood donations. The service ensures safe blood components for transfusion, specifically excluding patients with sickle cell disease, neonates, and paediatrics to prevent red cell sickling. The contract involves the supply of testing equipment and associated managed service support.
- Awarded value
- £98k
- As published
- Published
- 12 September 2025
- Contract length
- 60 months
- Ends 31 March 2031